This excerpt taken from the EYE DEF 14A filed Apr 25, 2008.
VIII. STOCKHOLDER APPROVAL
The Plan shall be submitted to the Companys stockholders for approval in accordance with the requirements of Section 162(m) of the Code, and the regulations promulgated thereunder, no later than the first regularly scheduled meeting of the Companys stockholders occurring more than twelve (12) months after the date of Allergan, Inc.s pro rata distribution to the holders of its common stock, $0.01 par value, of all the shares of Advanced Medical Optics, Inc. (the Company) common stock owned by Allergan, Inc. (the Distribution). No bonuses shall be paid with respect to 162(m) Participants under the Plan on or after such regularly scheduled meeting unless the Plan is approved in accordance with this Section VII and the requirements of Section 162(m) of the Code, and the regulations promulgated thereunder.